Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Atai Life Sciences N.V. (ATAI)

Atai Life Sciences N.V. (ATAI)
1.5000 +0.0400 (+2.74%) 08:52 ET [NASDAQ]
1.4600 x 3,400 1.5000 x 5,500
Realtime by (Cboe BZX)
1.4600 x 3,400 1.5000 x 5,500
Realtime 1.5000 +0.0400 (+2.74%) 08:52 ET
Quote Overview for Tue, Jan 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.5000
Day High
1.5000
Open 1.5000
Previous Close 1.4600 1.4600
Volume 15,493 15,493
Avg Vol 1,771,320 1,771,320
Stochastic %K 37.62% 37.62%
Weighted Alpha -35.43 -35.43
5-Day Change +0.0800 (+5.63%) +0.0800 (+5.63%)
52-Week Range 1.0300 - 2.8500 1.0300 - 2.8500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 244,991
  • Shares Outstanding, K 167,802
  • Annual Sales, $ 310 K
  • Annual Income, $ -40,220 K
  • EBIT $ -106 M
  • EBITDA $ -106 M
  • 60-Month Beta 1.19
  • Price/Sales 714.42
  • Price/Cash Flow N/A
  • Price/Book 1.67

Options Overview Details

View History
  • Implied Volatility 150.55% ( -34.85%)
  • Historical Volatility 94.67%
  • IV Percentile 67%
  • IV Rank 19.91%
  • IV High 591.81% on 10/03/24
  • IV Low 40.85% on 05/13/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 344
  • Volume Avg (30-Day) 965
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 31,707
  • Open Int (30-Day) 29,764

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.14
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.17
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1600 +29.31%
on 12/23/24
Period Open: 1.1900
1.9100 -21.47%
on 01/07/25
+0.3100 (+26.05%)
since 12/20/24
3-Month
1.0400 +44.23%
on 10/31/24
Period Open: 1.2000
1.9500 -23.08%
on 11/18/24
+0.3000 (+25.00%)
since 10/21/24
52-Week
1.0300 +45.63%
on 10/11/24
Period Open: 1.7000
2.8500 -47.37%
on 04/04/24
-0.2000 (-11.76%)
since 01/19/24

Most Recent Stories

More News
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination

Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...

CMPS : 3.58 (+2.58%)
PSIL : 12.82 (+1.99%)
ATAI : 1.5000 (+2.74%)
AZN : 67.68 (+1.62%)
BVNRY : 9.0075 (+0.70%)
NVAX : 8.47 (+0.83%)
MRNA : 35.72 (+4.87%)
CYBN : 9.50 (+4.05%)
GSK : 33.58 (+0.45%)
PFE : 26.40 (+0.38%)
BNTX : 112.00 (+0.06%)
SNY : 51.44 (+1.38%)
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 147.22 (+0.13%)
CMPS : 3.58 (+2.58%)
MNMD : 7.23 (+1.05%)
ATAI : 1.5000 (+2.74%)
ABBV : 171.98 (+0.24%)
This May be One of the Biggest Catalysts for Psychedelic Stocks in 2024

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression....

CMPS : 3.58 (+2.58%)
SEEL : 0.3900 (-27.79%)
ATAI : 1.5000 (+2.74%)
MNMD : 7.23 (+1.05%)
NUMI.TO : 0.0500 (+11.11%)
NUMIF : 0.0319 (+14.75%)
Breaking: The US FDA Just Granted Priority Review of an MDMA Treatment for PTSD

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change...

CMPS : 3.58 (+2.58%)
SEEL : 0.3900 (-27.79%)
ATAI : 1.5000 (+2.74%)
MNMD : 7.23 (+1.05%)
NUMI.TO : 0.0500 (+11.11%)
NUMIF : 0.0319 (+14.75%)
How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

EQNX::TICKER_START (NYSE:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(NASDAQ:ATAI) EQNX::TICKER_END

CYBN.NE : 13.3000 (+0.76%)
MMED.NE : 14.9000 (+9.48%)
CYBN : 9.50 (+4.05%)
ATAI : 1.5000 (+2.74%)
MNMD : 7.23 (+1.05%)
SEEL : 0.3900 (-27.79%)
CMPS : 3.58 (+2.58%)
3 Big New Catalysts for Psychedelics Stocks in 2024

This could be the year that psychedelics stocks start to fly.

CMPS : 3.58 (+2.58%)
ATAI : 1.5000 (+2.74%)
ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT

/CNW/ - This press release is being issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting...

ATAI : 1.5000 (+2.74%)
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis

EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END

ABBV : 171.98 (+0.24%)
ATAI : 1.5000 (+2.74%)
CMPS : 3.58 (+2.58%)
MNMD : 7.23 (+1.05%)
JNJ : 147.22 (+0.13%)
After Falling 60% in 1 Year, Is Atai Life Sciences Stock Still a Buy?

Atai's stock is hurting, but its pipeline is still packed with promising programs.

CMPS : 3.58 (+2.58%)
ATAI : 1.5000 (+2.74%)
Why Shares of Atai Life Sciences Rose Friday

The company's co-founder and chairman increased his position and explained why.

ATAI : 1.5000 (+2.74%)

Business Summary

atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.

See More

Key Turning Points

3rd Resistance Point 1.6069
2nd Resistance Point 1.5481
1st Resistance Point 1.5040
Last Price 1.5000
1st Support Level 1.4011
2nd Support Level 1.3423
3rd Support Level 1.2982

See More

52-Week High 2.8500
Fibonacci 61.8% 2.1548
Fibonacci 50% 1.9400
Fibonacci 38.2% 1.7252
Last Price 1.5000
52-Week Low 1.0300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Master Swing Trading: Strategies for Momentum and Trends